For the quarter ending 2026-03-31, PGEN has $138,627K in assets. $118,392K in debts. $7,480K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 7,480 | 30,234 | 14,322 | 13,760 |
| Short-term investments | 48,766 | 67,624 | 106,813 | 45,993 |
| Trade, less allowance for credit losses of 0 as of both march31, 2026 and december31, 2025 | 26,403 | 3,916 | 580 | 327 |
| Other | 302 | 446 | 520 | 244 |
| Inventory | 14,725 | 9,581 | 3,059 | - |
| Prepaid expenses and other | 3,996 | 3,434 | 4,303 | 2,431 |
| Total current assets | 101,672 | 115,235 | 129,597 | 62,755 |
| Long-term investments | 489 | 2,511 | 2,508 | - |
| Property, plant and equipment, net | 13,219 | 13,758 | 14,813 | 14,695 |
| Intangible assets, net | 2,864 | 3,182 | 3,500 | 3,818 |
| Goodwill | 15,232 | 15,232 | 15,232 | 15,232 |
| Right-of-use assets | 4,369 | 4,679 | 4,861 | 4,806 |
| Other assets | 782 | 908 | 753 | 590 |
| Total assets | 138,627 | 155,505 | 171,264 | 101,896 |
| Accounts payable | 2,589 | 11,985 | 6,262 | 3,922 |
| Accrued compensation and benefits | 4,556 | 10,199 | 10,167 | 5,201 |
| Other accrued liabilities | 12,481 | 10,993 | 10,824 | 9,514 |
| Indemnification accruals | 0 | 2,476 | 3,213 | 3,213 |
| Deferred revenue | 410 | 517 | 480 | 413 |
| Current portion of lease liabilities | 1,068 | 1,136 | 1,123 | 930 |
| Total current liabilities | 21,104 | 37,306 | 32,069 | 23,193 |
| Outstanding principal balance | - | - | 100,000 | - |
| Unamortized debt discount and issuance costs | - | - | 7,110 | - |
| Long-term debt | 93,519 | 93,174 | 92,890 | - |
| Deferred revenue, net of current portion | - | 0 | 95 | 1,818 |
| Lease liabilities, net of current portion | 3,663 | 3,980 | 4,179 | 4,223 |
| Warrant liabilities | - | 0 | 0 | 78,558 |
| Other long-term liabilities | 106 | 134 | 163 | - |
| Total liabilities | 118,392 | 134,594 | 129,396 | 107,792 |
| Series a preferred stock, no par value, 81,000 shares authorized as of december31, 2025 and december31, 2024 zero and 79,000 shares issued and outstanding as of december31, 2025 and december31, 2024, respectively (aggregate liquidation preference of zero as of december31, 2025 and 79,000 as of december31, 2024) | - | 0 | 0 | 30,883 |
| Common stock, no par value, 700,000,000 shares authorized as of march31, 2026 and december31, 2025 355,903,977 shares and 353,910,926 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively | 0 | 0 | 0 | 0 |
| Additional paid-in capital | 2,369,529 | 2,362,252 | 2,359,689 | 2,134,711 |
| Accumulated deficit | -2,349,277 | -2,341,348 | -2,317,845 | -2,171,501 |
| Accumulated other comprehensive (loss) income | -17 | 7 | 24 | 11 |
| Total shareholders' equity | 20,235 | 20,911 | 41,868 | -36,779 |
| Total liabilities and shareholders' equity | 138,627 | 155,505 | 171,264 | 101,896 |
PRECIGEN, INC. (PGEN)
PRECIGEN, INC. (PGEN)